Personalis (PSNL) Projected to Post Quarterly Earnings on Thursday

Personalis (NASDAQ:PSNL) is expected to be issuing its quarterly earnings data after the market closes on Thursday, February 27th. Analysts expect the company to announce earnings of ($0.32) per share and revenue of $15.48 million for the quarter. Individual that wish to register for the company’s earnings conference call can do so using this link.

Personalis Price Performance

PSNL stock opened at $4.23 on Wednesday. Personalis has a 52-week low of $1.13 and a 52-week high of $7.20. The company has a 50-day moving average of $5.43 and a two-hundred day moving average of $5.05. The stock has a market capitalization of $298.84 million, a price-to-earnings ratio of -2.52 and a beta of 1.73.

Wall Street Analyst Weigh In

Several equities research analysts recently weighed in on PSNL shares. HC Wainwright reduced their target price on shares of Personalis from $11.00 to $8.00 and set a “buy” rating for the company in a research note on Monday, January 27th. Lake Street Capital raised their price objective on shares of Personalis from $7.00 to $9.00 and gave the stock a “buy” rating in a report on Wednesday, January 8th. Finally, Needham & Company LLC restated a “buy” rating and issued a $7.25 price objective on shares of Personalis in a research report on Wednesday, January 8th.

About Personalis

Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.